← Dow overview

Dow vs Solstice Advanced Materials: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Dow Inc (DOW)

Q3 2026
▼3

Dow Falls on Tariffs, Weak Polyethylene, and Downgrades

  • Canada tariffs raise export costs Canada's retaliatory tariffs are increasing Dow's export costs, making its products less competitive and pressuring profit margins. This adds a new trade-related headwind to an already difficult commodity environment.

    New tariff development directly hurts Dow's cost structure and pricing power.

  • Q3 EBITDA guidance cut on weak demand Dow lowered its third-quarter EBITDA guidance to $1.5–1.6 billion, citing weak polyethylene prices and soft construction and auto demand. This signals that core end markets remain sluggish and earnings recovery is delayed.

    Guidance cut is a fresh negative signal about current profitability.

  • Citi downgrade and price target cut Citi downgraded Dow to Neutral and slashed its price target to $30, also cutting 2027 earnings estimates. This reflects growing analyst skepticism about Dow's near-term earnings power and valuation.

    New analyst downgrade directly lowers market expectations for the stock.

  • Debt paydown, dividend halved, Sadara stake sale weighed Dow is prioritizing debt reduction over buybacks and preserving its halved $0.35 dividend. It is also considering selling its Sadara stake for cash, though that would forfeit future recovery upside. Cost cuts and working-capital release provide some offset.

    New capital allocation decisions and potential asset sale affect financial flexibility and shareholder returns.

August 2026
▼3

Dow Falls on Tariffs, Weak Polyethylene, and Downgrades

  • Canada tariffs raise export costs Canada's retaliatory tariffs are increasing Dow's export costs, making its products less competitive and pressuring profit margins. This adds a new trade-related headwind to an already difficult commodity environment.

    New tariff development directly hurts Dow's cost structure and pricing power.

  • Q3 EBITDA guidance cut on weak demand Dow lowered its third-quarter EBITDA guidance to $1.5–1.6 billion, citing weak polyethylene prices and soft construction and auto demand. This signals that core end markets remain sluggish and earnings recovery is delayed.

    Guidance cut is a fresh negative signal about current profitability.

  • Citi downgrade and price target cut Citi downgraded Dow to Neutral and slashed its price target to $30, also cutting 2027 earnings estimates. This reflects growing analyst skepticism about Dow's near-term earnings power and valuation.

    New analyst downgrade directly lowers market expectations for the stock.

  • Debt paydown, dividend halved, Sadara stake sale weighed Dow is prioritizing debt reduction over buybacks and preserving its halved $0.35 dividend. It is also considering selling its Sadara stake for cash, though that would forfeit future recovery upside. Cost cuts and working-capital release provide some offset.

    New capital allocation decisions and potential asset sale affect financial flexibility and shareholder returns.

Latest
▼2▲1

Dow's recovery hopes fade as analysts cut estimates on weak demand

  • Citi downgrades Dow, slashes price target and 2027 profit forecast Citi cut Dow to Neutral from Buy, lowered its price target to $30 from $35, and reduced its 2027 earnings estimate to $1.21 from $1.83. The analyst said weak demand means even $100 oil won't lift polyethylene prices much, so Dow's profit recovery looks smaller and further away.

    This is the most recent and most concrete negative signal, directly cutting the earnings and price outlook that drive DOW's valuation.

  • Analysts trim Dow estimates ahead of October 22 earnings Ahead of Dow's October 22 earnings report, analysts lowered their profit estimates over the past month, and the stock fell 1% to $27.61, down 8.62% in a month. Lower expectations mean even a decent quarter may not be enough to lift the shares.

    Shows the market's expectations are falling into the key earnings event, a direct drag on DOW's price.

  • Univar expands distribution of Dow's SupraCare products across US and Canada Univar widened its agreement to distribute Dow's SupraCare polymers and specialty additives in the US and Canada, reaching more homecare and industrial cleaning customers. This is a real but modest boost to Dow's sales reach, though it doesn't fix the bigger problem of weak overall chemical demand.

    A concrete new demand-side positive for Dow, but small relative to the demand and pricing headwinds.

  • Dow screens as undervalued, but a peer looks cheaper One analysis said Dow is undervalued, worth about $38 a share based on cash flow, while another preferred LyondellBasell because it's cheaper and lost less money. The bull case rests on Dow's low price, but weak demand and high costs keep the discount in place.

    Captures the valuation debate that frames whether DOW is a bargain or a value trap, a key part of the big picture.

▼2

Dow cuts outlook, faces Canada tariffs, weighs Sadara sale

  • Canada tariffs hit Dow exports Canada's retaliatory tariffs on U.S. goods took effect September 8, hitting plastics and chemicals that include Dow products. This makes Dow's exports to Canada more expensive, likely reducing sales and pressuring profit.

    New trade barrier directly affecting Dow's sales and pricing power.

  • Dow weighs selling Sadara stake Dow is reportedly considering selling its 35% stake in the $20 billion Sadara joint venture with Saudi Aramco. A sale could bring cash but forfeit future recovery upside, and the headline $20 billion is not the current value of Dow's stake.

    Portfolio move with major cash and strategic implications for Dow's balance sheet.

  • Dow trims Q3 EBITDA outlook Dow cut its third-quarter EBITDA forecast to $1.5–1.6 billion, citing weaker polyethylene pricing in the Americas and soft construction and automotive demand. This signals near-term earnings pressure, though cost cuts and working-capital release offer some offset.

    Direct reduction in expected earnings, a key driver of stock value.

  • Debt paydown prioritized over buybacks Dow will use excess cash to reduce debt and does not expect share buybacks in 2026, keeping the $0.35 dividend as the main shareholder return. This strengthens the balance sheet but removes a potential stock support, and the dividend is half its former level.

    Capital allocation shift affects shareholder returns and financial risk.

Q2 2026
▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

  • RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.

    This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.

  • Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.

    This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.

  • Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.

    This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.

  • Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.

    These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

June 2026
▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

  • RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.

    This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.

  • Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.

    This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.

  • Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.

    This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.

  • Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.

    These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

  • RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.

    This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.

  • Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.

    This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.

  • Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.

    This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.

  • Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.

    These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

Solstice Advanced Materials, Inc (SOLS)

Q3 2026
▲2▼1

Solstice's $14.5B Deal Scrapped, Buyback and Strong Q2 Lift Shares

  • Element Solutions Acquisition and Termination Solstice's $14.5B deal for Element Solutions initially sank shares 15% on dilution and debt worries, but was later terminated after shareholder pushback, removing a major overhang.

    This was the biggest event of the quarter, causing a sharp drop and then relief.

  • Strong Q2 Results and Raised Guidance Solstice reported Q2 sales of $1.15B, up 11%, and raised its full-year guidance, signaling robust demand and operational momentum.

    Strong financial results and improved outlook are key positive drivers for the stock.

  • First-Ever $500M Buyback The company announced its first-ever $500M share buyback, a move that can boost earnings per share and shows confidence in future cash flows.

    Buybacks often lift stock prices by reducing share count and signaling management optimism.

  • Secular Growth vs. Analyst Caution Growth drivers in uranium conversion and AI/semiconductor materials are promising, but analysts are split: BMO cut its target to $83, and UBS warned higher rates and weak sector growth could limit gains.

    This captures the tug-of-war between long-term opportunities and near-term headwinds.

August 2026
▲3

Solstice Goes Standalone After Deal Collapse, Q2 Beats

  • Element Solutions merger terminated Solstice called off its $14.5 billion merger with Element Solutions after shareholders objected. The move removes a major overhang that had weighed on the stock, as investors had worried about dilution and debt from the deal.

    The termination is a major new event that directly affects Solstice's ownership and capital structure.

  • Strong Q2 results and raised guidance Solstice reported second-quarter sales of $1.15 billion, up 11% from a year earlier, and raised its full-year 2026 guidance. The results show the standalone business is growing faster than expected, supporting the bull case.

    Q2 earnings and guidance are fresh fundamental data that can drive investor confidence and price.

  • First-ever $500 million buyback Solstice announced its first-ever share buyback program of $500 million. Buybacks reduce the number of shares outstanding, which can boost earnings per share and signal management's confidence in the company's future.

    A new capital return program is a concrete action that can support the stock price.

  • Analyst split and macro headwinds After the deal collapse, BMO cut its price target to $83 from $95 but kept a Buy rating. UBS added Solstice to its industrial capex list with an $80 target, yet warned higher interest rates and weak sector growth could limit gains.

    Analyst reactions and macro warnings provide a balanced view of the risks and rewards ahead.

Latest
▲4

Solstice Kills $14.5B Deal, Goes Independent With Buyback and R&D Push

  • Solstice scraps $14.5B Element deal, stays independent Solstice and Element Solutions mutually ended their $14.5 billion merger after shareholders pushed for independence, with no breakup fee. The deal had dragged Solstice shares down, so walking away removes that overhang. Solstice also reaffirmed raised guidance and reported second-quarter sales up 11% to $1.148 billion.

    The termination is the single biggest new event and reverses the deal that had been weighing on the stock.

  • First-ever $500 million buyback authorized Solstice's board approved its first-ever share buyback of up to $500 million. Buying back stock can lift the share price by shrinking the number of shares and signaling management believes the stock is undervalued. It also puts the company's cash to work after staying independent.

    A new capital-return action that directly supports the share price and shows confidence.

  • UBS adds Solstice to industrial capital-spending list UBS named Solstice one of 10 industrial stocks set to benefit from a broader capital-spending cycle, with an $80 price target. That implies meaningful upside and draws investor attention to Solstice as manufacturing demand recovers. UBS flagged higher interest rates and weak growth as risks to the sector.

    A fresh analyst endorsement that frames Solstice as a beneficiary of an improving industrial cycle.

  • $49 million Buffalo R&D expansion with state support Solstice will invest $49 million to expand its Buffalo research campus, backed by up to $1.4 million in New York tax credits. The project adds labs for refrigerants, thermal management and energy storage, plus 12 new jobs by June 2027. It signals long-term growth investment in its core businesses.

    A concrete new investment showing Solstice is funding future growth after the deal fell through.

▲3

Solstice Goes It Alone: Merger Scrapped, Buyback and Guidance Lift Stock

  • Standalone pure-play after Honeywell breakup Honeywell finished splitting into four companies, leaving Solstice as a standalone specialty materials business focused on refrigerants and nuclear materials. Investors often pay more for a focused company than a conglomerate piece, which can lift the shares over time.

    This is the structural event that created SOLS as an independent stock and frames all later news.

  • Strong Q2 and raised 2026 guidance Solstice's second-quarter sales rose 11% to $1.15 billion, beating its own forecast, and it raised full-year sales and profit guidance. Management said the heaviest plant maintenance is done, which should help margins in the second half.

    Better-than-expected results and higher guidance are a direct, fundamental reason the stock can rise.

  • Merger with Element Solutions terminated; $500M buyback Solstice and Element Solutions called off their $14.5 billion merger with no fees, after shareholder pushback. Solstice then authorized its first $500 million share buyback and kept its 2026 sales guidance, sending the stock up 12.8% as investors welcomed the standalone path.

    This is the period's biggest new event and the main reason SOLS moved sharply higher.

  • Analyst views split after the deal collapse UBS had upgraded Solstice to Buy in July, saying the stock was undervalued and could grow earnings about 18% a year. After the merger ended, BMO cut its price target to $83 from $95 but kept a Buy rating, showing support but also caution about the standalone plan.

    It shows the real counterweight: analysts still see value but have trimmed expectations after the merger fell through.

July 2026
▲3▼1

Solstice's $14.5B Element Deal Shakes Stock, But Growth Story Intact

  • Solstice to acquire Element Solutions for $14.5B, shares drop 15% Solstice announced a $14.5 billion cash-and-stock deal to buy Element Solutions, sending its shares down nearly 15%. The deal dilutes existing shareholders and adds debt, which worries investors. The market's negative reaction shows concern about the price paid and integration risks.

    This is the major new event that directly caused a sharp stock drop and dominates the period.

  • CEO and Cramer defend deal, call pullback a buying opportunity Solstice's CEO said Wall Street misread the deal, blaming hedge funds and arbitrage traders for the sell-off. Jim Cramer called the merger 'very smart' and the pullback a 'terrific buying opportunity.' These endorsements may boost investor confidence and support a price recovery.

    This is new this period and provides a counterweight to the negative market reaction, potentially influencing price direction.

  • Solstice's uranium conversion and AI materials demand drive growth Solstice is the sole US utility-scale provider of uranium conversion services, with strengthening demand prompting capacity expansion. It also supplies specialty materials for AI data centers and semiconductors, benefiting from surging demand. These secular growth drivers underpin the long-term investment case.

    This explains the fundamental demand forces behind Solstice's growth story, which is key to understanding its valuation.

  • Solstice stock up 66% since spinoff, trades at premium valuation Since spinning off from Honeywell nine months ago, Solstice shares have surged about 66%, trading at 30 times forward earnings with expected earnings growth over 20%. The company offers exposure to AI and nuclear energy themes, attracting investor interest despite the recent pullback.

    This provides context on the stock's strong performance and valuation, helping investors assess the current opportunity.

▲3▼1

Solstice's $14.5B Element Deal Shakes Stock, But Growth Story Intact

  • Solstice to acquire Element Solutions for $14.5B, shares drop 15% Solstice announced a $14.5 billion cash-and-stock deal to buy Element Solutions, sending its shares down nearly 15%. The deal dilutes existing shareholders and adds debt, which worries investors. The market's negative reaction shows concern about the price paid and integration risks.

    This is the major new event that directly caused a sharp stock drop and dominates the period.

  • CEO and Cramer defend deal, call pullback a buying opportunity Solstice's CEO said Wall Street misread the deal, blaming hedge funds and arbitrage traders for the sell-off. Jim Cramer called the merger 'very smart' and the pullback a 'terrific buying opportunity.' These endorsements may boost investor confidence and support a price recovery.

    This is new this period and provides a counterweight to the negative market reaction, potentially influencing price direction.

  • Solstice's uranium conversion and AI materials demand drive growth Solstice is the sole US utility-scale provider of uranium conversion services, with strengthening demand prompting capacity expansion. It also supplies specialty materials for AI data centers and semiconductors, benefiting from surging demand. These secular growth drivers underpin the long-term investment case.

    This explains the fundamental demand forces behind Solstice's growth story, which is key to understanding its valuation.

  • Solstice stock up 66% since spinoff, trades at premium valuation Since spinning off from Honeywell nine months ago, Solstice shares have surged about 66%, trading at 30 times forward earnings with expected earnings growth over 20%. The company offers exposure to AI and nuclear energy themes, attracting investor interest despite the recent pullback.

    This provides context on the stock's strong performance and valuation, helping investors assess the current opportunity.